Tokyo (JCNN) - Sawai Pharmaceutical (TSE: 4555), a Japanese pharmaceutical specialized in manufacturing generic products, announced on April 13 that it has basically agreed with Nihon Schering on an upcoming business transfer.
Specifically, Sawai will take over all fixed assets of Nihon Schering’s Mobara plant including facilities, related operations and trained employees, as of October 1.